Research Management Group (RMG)

The V Foundation for Cancer Research
Translational Award Program

Limited funding opportunity for Stanford faculty with UTL, MCL, and NTLR appointments. This $600,000 Translational Award Program supports research teams to conduct translational cancer research in any cancer area. Please see Stanford eligibility clarification below.


The 2018 internal deadline has passed. This webpage is for your reference only.

# applicants: 1

Stanford Cancer Institute internal deadline (one page proposal):  Monday,  April 2, 2018, 5 p.m. (see internal submission guidelines below)
Cancer Institute will notify the applicant selected: April 13, 2018
Cancer Institute to submit the applicant's contact information to the foundation: April 16, 2018, 5 p.m. ET
(The foundation will then contact the applicant to provide the online application system.)
Completed PDRF form and complete application materials must be submitted to the applicant's RPM: May 23, 2018
Online application to be submitted to the V Foundation:   May 30, 2018, 5 p.m. ET


Download a PDF file of the guidelines

Previous grant recipients:

Amount of funding:
The Translational Research Award is a $600,000 grant awarded in three annual installments of $200,000. Indirect costs up to a maximum of 10% within the total award are permitted.

The nominated applicant must be the lead Principal Investigator (PI) on the Translational Award research team. The applicant must meet all of the following criteria to be eligible to submit an application:

Note: The final application will be submitted through the Cancer Institute.


The V Foundation submits Requests for Proposals (RFPs) to the directors of the National Cancer Institute (NCI)-designated facilities and prominent universities involved in critical cancer research throughout the United States. The V Foundation for Cancer Research seeks to support translational research projects within the scope of all types of cancers.

Special Focus area:
As in previous years, any area of cancer research is permitted.

However, we will again encourage research on the biological basis of cancer disparities experienced by patients from minority ethnic or racial populations in areas related to causes, aggressiveness, treatment or relapse. Cancers in which ethnic and racial disparities have previously been demonstrated include: lung and bronchus, colon and rectum, breast, prostate, uterine, cervix, stomach and liver. As in 2017, among our highly ranked finalists for the 2018 Translational Award program, we will designate at least one of the highest ranked applications as the recipient of a Stuart Scott Memorial Cancer Research Fund Translational Research Award.

Definition of a translational research project:
Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than 3 years. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial.


By  Monday, April 2, 2018, 5 p.m. please submit one PDF file [File name: Last name_V_Fdn_Translational.pdf] of the following via email attachment to:

Denise Baughman
Project Manager
Stanford Cancer Institute

One page summary describing your research project
The V Foundation for Cancer Research
Translational Research Grant Program
Lead PI name, title, type of appointment (UTL or MCL), department, email address
Collaborating investigator(s) names, titles, departments, email addresses
Project title



Denise Baughman
Project Manager
Administration Office
Stanford Cancer Institute
Lorry Lokey Stem Cell Building/SIM 1
265 Campus Drive
Stanford, CA 94305-5456
t 650-724-9547
f 650-736-0607


Footer Links: